MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer

Clinical trial NCT06980519 · AVAILABLE

Trial details

NCT number: NCT06980519
Sponsor: Monopar Therapeutics
Status: AVAILABLE
Study type: EXPANDED_ACCESS

Cancer Solid Tumor Solid Tumor Cancer Oncology uPAR-positive Solid Tumor Urokinase Plasminogen Activator Receptor-positive Solid Tumor

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.